The health minister of Jordan, Nathir Obeidat, said on 25 February 2021 that the country's national inoculation programme will speed up significantly in coming weeks as more COVID-19 vaccines arrive, Reuters news agency repaired on Friday.
Obeidat was quoted as telling old state-funded public broadcaster al Mamlaka: "Inoculation will speed up in the next few weeks and coming few months."
According to Obeidat, Jordan is set to shortly receive 2.2 million doses of Pfizer- BioNTech's COVID-19 vaccine. The government had said earlier this year that it had struck a deal to buy one million doses.
Reportedly, most of the COVID-19 vaccines that have arrived in small weekly batches so far have been from Pfizer-BioNTech, although the government has also received undisclosed quantities from the UAE of China's SinoPharm COVID-19 vaccine.
The first shipments of AstraZeneca Plc's COVID-19 vaccine, which was granted provisional approval this week, will also arrive in the next two weeks, Obeidat said, adding that the country had the resources to inoculate as many as 40,000 people daily.
So far, Jordan has administered 150,000 COVID-19 vaccine doses since it began its vaccination programme over a month ago.
Reportedly, only 400,000 people has so far signed up for the free shots since the government-run registration began in December 2020, with officials urging more people in the country of ten million to register. Priority is being given to the over-60s.
So far, Jordan has reported 380,268 COVID-19 cases and 4,627 deaths.
EpiVax introduces AI-enhanced models for immunogenicity prediction
Pfizer and BioNTech granted FDA approval for XFG-adapted COVID-19 vaccine
4basebio announces strategic collaboration with Genezen
Charles River and Medigen collaborate on next-generation enterovirus vaccine development
Piramal Pharma acquires controlling stake in Yapan Bio
Innorna Nominated for 2026 Prix Galien USA Best Startup Award
Sanofi's MenQuadfi receives EU approval for infants from six weeks
Evaxion to present three-year cancer vaccine data at ESMO Congress 2026
Evaxion presents new preclinical data on cytomegalovirus vaccine EVX-V1
Northwest Biotherapeutics presents on propensity score matching at BNOS 2026
Taiwan biomedical startups hold over 100 business meetings at BIO 2026
SK bioscience to lead Gates Foundation-funded ROTOR project
Anixa Biosciences' breast cancer vaccine technology granted first Korean patent
Transgene expands myvac platform into non-small cell lung cancer with TG4070